This company may still be operating, however this listing is no longer active. Find out why through their latest events.

Clinical Laserthermia Systems Toekomstige groei

We currently don't have sufficient analyst coverage to forecast growth and revenue for Clinical Laserthermia Systems.

56.9%

Groei van de winst

50.0%

Groei van de winst per aandeel

Medical Equipment winstgroei	30.4%
Inkomstengroei	56.5%
Toekomstig rendement op eigen vermogen	n/a
Dekking van analisten	Low
Laatst bijgewerkt	24 Feb 2023

Geen updates

Geen updates

Winst- en omzetgroeiprognoses

OM:CLS UR B - Toekomstschattingen van analisten en financiële gegevens uit het verleden (SEK Millions )
Datum	Inkomsten	Inkomsten	Vrije kasstroom	Geldmiddelen uit operationele activiteiten	Gem. Aantal analisten
12/31/2025	115	-2	N/A	N/A	1
12/31/2024	44	-45	-48	-45	1
12/31/2023	17	-70	-70	-67	1
3/31/2023	6	-78	-71	-68	N/A
12/31/2022	6	-71	-69	-68	N/A
9/30/2022	3	-81	-81	-81	N/A
6/30/2022	2	-63	-66	-66	N/A
3/31/2022	2	-68	-71	-71	N/A
12/31/2021	2	-64	-67	-66	N/A
9/30/2021	1	-60	-63	-63	N/A
6/30/2021	2	-57	-55	-55	N/A
3/31/2021	2	-47	-41	-41	N/A
12/31/2020	1	-58	-56	-55	N/A
9/30/2020	1	-58	-54	-53	N/A
6/30/2020	2	-57	-54	-54	N/A
3/31/2020	6	-54	-52	-52	N/A
12/31/2019	6	-43	-39	-39	N/A
9/30/2019	6	-38	-37	-36	N/A
6/30/2019	5	-37	-35	-34	N/A
3/31/2019	1	-41	-44	-43	N/A
12/31/2018	8	-33	-41	-39	N/A
9/30/2018	10	-28	-33	-31	N/A
6/30/2018	11	-24	-33	-31	N/A
3/31/2018	12	-15	-29	-24	N/A
12/31/2017	8	-21	-29	-24	N/A
9/30/2017	8	-22	-34	-29	N/A
6/30/2017	8	-26	-28	-24	N/A
3/31/2017	6	-27	-24	-23	N/A
12/31/2016	4	-27	N/A	-20	N/A
9/30/2016	1	-27	N/A	-19	N/A
6/30/2016	0	-23	N/A	-22	N/A
3/31/2016	0	-20	N/A	-17	N/A
12/31/2015	N/A	-17	N/A	-19	N/A
9/30/2015	0	-21	N/A	-21	N/A
6/30/2015	0	-20	N/A	-20	N/A
3/31/2015	0	-20	N/A	-19	N/A
12/31/2014	N/A	-18	N/A	-16	N/A
9/30/2014	0	-16	N/A	-18	N/A
6/30/2014	N/A	-16	N/A	-18	N/A
3/31/2014	N/A	-17	N/A	-17	N/A
12/31/2013	N/A	-18	N/A	-18	N/A
9/30/2013	0	-16	N/A	-13	N/A
6/30/2013	N/A	-15	N/A	-12	N/A
3/31/2013	0	-13	N/A	-11	N/A
12/31/2012	N/A	-13	N/A	-12	N/A
9/30/2012	0	-11	N/A	-10	N/A

Verdiensten versus spaarpercentage: CLS UR B is forecast to remain unprofitable over the next 3 years.

Winst versus markt: CLS UR B is forecast to remain unprofitable over the next 3 years.

Hoge groeiwinsten: CLS UR B is forecast to remain unprofitable over the next 3 years.

Omzet versus markt: CLS UR B's revenue (56.5% per year) is forecast to grow faster than the Swedish market (5.5% per year).

Hoge groei-inkomsten: CLS UR B's revenue (56.5% per year) is forecast to grow faster than 20% per year.

Toekomstige ROE: Insufficient data to determine if CLS UR B's Return on Equity is forecast to be high in 3 years time